Digital Phablet

Tag: study finds

  • Ancient Chinese Exercise Boosts Blood Pressure Health, Study Shows

    Ancient Chinese Exercise Boosts Blood Pressure Health, Study Shows

    High blood pressure remains one of the most widespread health issues globally. Millions live with it daily, often unaware of its potential dangers. Persistent high blood pressure forces the heart and blood vessels to work harder than normal, which over time can cause damage to the heart, brain, kidneys, and arteries. This increases the likelihood of heart attacks, strokes, kidney problems, and heart failure.

    For years, doctors have recommended exercise as a natural method to help manage blood pressure. Regular physical activity can strengthen the heart, boost circulation, and keep blood vessels healthy and flexible. However, many people find it challenging to stick with exercise routines long-term. Gym memberships can be costly, workouts may feel too intense, and motivation often dwindles after a few weeks or months.

    Recent research points to an ancient Chinese exercise called baduanjin as a simple, accessible way to lower blood pressure. A large clinical trial published in the Journal of the American College of Cardiology (JACC) examined this practice. The study found that individuals practicing baduanjin experienced significant drops in blood pressure within just three months, with improvements lasting up to a year.

    Baduanjin, meaning “Eight Pieces of Brocade,” has been performed for over 800 years. It involves eight slow, deliberate movements combined with gentle stretching, controlled breathing, balance, meditation, and mindfulness. Unlike many modern workouts, it requires no special equipment or gym space and can be practiced outdoors in parks or community areas.

    A typical session lasts only about 10 to 15 minutes. Its low-impact, slow movements make it suitable for most adults, including seniors or those unable to perform high-intensity exercises.

    In the study, 216 adults from seven Chinese communities participated. All were at least 40 years old with systolic blood pressure readings between 130 and 139 mm Hg (classified as stage 1 hypertension). Participants were divided into three groups: one practiced baduanjin five days a week, another engaged in brisk walking, and the third followed self-directed exercise routines.

    Over one year, researchers monitored blood pressure at 12-week and 52-week intervals. Results showed that those practicing baduanjin lowered their 24-hour systolic blood pressure by approximately 3 mm Hg and reduced blood pressure readings at the doctor’s office by about 5 mm Hg compared to self-guided exercisers. These reductions are comparable to those achieved by some blood pressure medications.

    Importantly, improvements appeared quickly and persisted throughout the study. Baduanjin performed as well as brisk walking after a year and offers a more accessible alternative for people who dislike or cannot perform strenuous exercise.

    One significant advantage observed was the high adherence rate; participants successfully maintained the routine over the long term. Since many lifestyle programs falter due to complexity or inconvenience, this simple, inexpensive practice could be a sustainable option for many.

    Dr. Jing Li, a senior researcher and director at Beijing’s National Center for Cardiovascular Diseases, highlighted that baduanjin could become a practical lifestyle intervention for blood pressure management. The practice’s combination of physical movement, mindfulness, and controlled breathing may also help reduce stress—a known factor in high blood pressure.

    The findings gained attention among cardiology experts worldwide. Dr. Harlan Krumholz of Yale Medicine described the results as particularly promising, noting that this gentle exercise produced benefits similar to medication without the associated costs or side effects. Its low resource requirements make it especially valuable in areas with limited healthcare access.

    While these results are encouraging, experts caution that baduanjin should not replace medical treatment prescribed by healthcare professionals, especially for individuals with severe hypertension or heart disease. Those with serious health conditions should continue to follow their doctor’s advice.

    Overall, this study suggests that simple, gentle exercises like baduanjin can have significant health benefits. For many, particularly older adults or those struggling with traditional workouts, it provides a safe, manageable way to improve heart health and keep blood pressure under control.

  • Omega-3 Supplements May Accelerate Cognitive Decline, Study Shows

    Omega-3 Supplements May Accelerate Cognitive Decline, Study Shows

    Credit: Unsplash+


    Omega-3 supplements have gained significant popularity among older adults worldwide.

    Many individuals daily take fish oil capsules, believing these supplements can help safeguard the heart, boost memory, and decrease the risk of developing dementia as they age.

    For years, omega-3 fatty acids have been widely promoted as “brain-friendly” nutrients. These fats naturally occur in fatty fish such as salmon, sardines, and mackerel, and are recognized for their vital role in brain development and overall bodily functions.

    As a result, numerous supplement brands market omega-3 capsules as an easy approach to support healthy aging and ward off memory deterioration.

    However, a recent study raises questions about whether omega-3 supplements truly help seniors maintain cognitive health.

    Researchers from China analyzed long-term brain and cognitive data and found that individuals taking omega-3 supplements seemed to experience a quicker decline in cognitive abilities compared to those who didn’t take them.

    The findings were published in The Journal of Prevention of Alzheimer’s Disease.

    The study involved older adults participating in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a large-scale project tracking people over time to better understand how Alzheimer’s develops and how brain aging occurs.

    Scientists examined five years’ worth of data from 273 regular omega-3 users and compared it with 546 non-users.

    Participants were carefully matched in terms of age, gender, genetics, and diagnosis to ensure fair comparisons.

    The participants underwent multiple brain scans and completed various standard cognitive assessments that measure memory, reasoning, and overall mental function.

    The results surprised the researchers.

    Those taking omega-3 supplements exhibited a faster decline on all major cognitive tests used throughout the study. These included the MMSE, ADAS-Cog13, and CDR-SB, which are commonly used markers for tracking cognitive decline and dementia progression.

    The team also explored whether genetics could explain these differences.

    Both groups had similar numbers of individuals carrying the APOE ε4 gene—a well-known genetic risk factor for Alzheimer’s disease. Since genetic distribution was comparable, it is unlikely that genetics alone accounts for the faster decline seen in omega-3 users.

    To understand the underlying changes inside the brain, scientists closely studied detailed brain imaging results.

    Interestingly, they found no evidence that omega-3 users had more amyloid plaques or tau protein buildup, which are considered core biological indicators of Alzheimer’s disease.

    Instead, the brain scans revealed a different pattern.

    People taking omega-3 supplements showed a more significant decrease in brain glucose metabolism over time.

    Glucose serves as the brain’s primary energy source. For brain cells to communicate and function properly, they depend heavily on glucose. A decline in glucose metabolism is often linked to synaptic dysfunction, meaning connections between brain cells may not work as efficiently.

    This suggests that while the brain’s physical structure might look relatively intact, the communication pathways between neurons could be weakening gradually.

    The researchers believe this decrease in brain energy activity may help explain the accelerated cognitive decline observed in supplement users.

    These findings are significant because omega-3 supplements are generally considered safe and beneficial by many.

    Previous animal studies and observational research suggested omega-3 fats might help reduce inflammation, protect brain cells, and lower the risk of dementia. Yet, large-scale controlled human studies have produced mixed or unimpressive results.

    Some experts think differences could be due to dosage, supplement quality, timing of use, or whether omega-3 is consumed through food or pills.

    The scientists emphasize that their results do not prove omega-3 supplements cause cognitive decline directly.

    This was an observational study, which only shows an association between supplement use and brain changes. It cannot establish cause and effect.

    Other hidden factors could still influence the findings. For instance, some individuals might have started taking omega-3s because they were already experiencing memory concerns or early cognitive issues.

    Further clinical trials are necessary before making definitive conclusions.

    Nonetheless, these findings challenge the common notion that omega-3 supplements are invariably beneficial for brain health in older adults.

    The study highlights a broader issue in nutrition science: many supplements gain popularity based on early research, marketing, or public enthusiasm, well before substantial long-term evidence is available.

    It’s important to remember that “natural” does not always mean risk-free or universally advantageous.

    For now, most health experts still recommend a balanced diet rich in whole foods, vegetables, fruits, fish, along with regular exercise, good sleep, and blood pressure management as the most reliable ways to support brain health as we age.

    Researchers hope future studies will clarify whether certain groups benefit from omega-3 supplements and others do not.

    Overall, the study suggests a need for caution and more scientific investigation before confidently recommending omega-3 supplements as a long-term strategy for preventing memory decline or dementia.

    If you’re interested in maintaining brain health, explore research on how reducing inflammation might slow cognitive aging, or how vitamin D levels could influence mental decline.

    Additional studies highlight effective exercises for brain health and diets like MIND that may help safeguard cognitive function and prevent dementia.

    Source: Alzheimer’s Disease Neuroimaging Initiative.


  • Younger Adults Face Rising Risk of Rectal Cancer, Study Reveals

    Younger Adults Face Rising Risk of Rectal Cancer, Study Reveals

    Rectal cancer is increasingly affecting younger adults, with recent studies indicating that the situation may be worsening faster than previously thought. Traditionally, colorectal cancer was perceived as a disease predominantly impacting older individuals, leading medical professionals to focus screening efforts on those over age 50, while younger populations were rarely considered at high risk. However, new research challenges this assumption.

    Led by Mythili Menon Pathiyil from SUNY Upstate Medical University, a study to be presented at Digestive Disease Week (DDW 2026) reveals an alarming trend: the mortality rate from rectal cancer among younger adults, particularly late millennials, is rising rapidly. Notably, the increase in rectal cancer deaths outpaces the rise in colon cancer deaths within the same age group.

    Researchers analyzed U.S. death records from 1999 through 2023, using data from the CDC’s database, focusing on adults aged 20 to 44. This extensive dataset enabled a detailed examination of patterns across various demographics, including gender, ethnicity, and geographic region.

    The findings show a consistent increase in colorectal cancer deaths among younger adults, with rectal cancer-related fatalities showing an especially steep upward trajectory. Across multiple groups, rectal cancer mortality is climbing two to three times faster than that of colon cancer. The rise is particularly notable among adults aged 35 to 44, and projections suggest this trend will continue in the foreseeable future.

    Using statistical models, researchers forecast that rectal cancer deaths will persist in their upward trend through 2035, especially among individuals in their late 30s and early 40s. Certain populations, such as Hispanic adults and those residing in the Western United States, are experiencing the most rapid increases.

    These numbers raise critical questions regarding current approaches to cancer detection and treatment in younger populations. Symptoms like rectal bleeding or bowel habit changes are often overlooked or misinterpreted as benign issues, such as hemorrhoids, leading to delays in diagnosis. The study highlights that young patients typically experience longer waits before receiving treatment—sometimes several months—compared to older adults, who often initiate treatment within about a month of symptom onset. These delays can allow the disease to advance to more difficult-to-treat stages.

    Both healthcare providers and patients need increased awareness of these risks. There’s also a growing conversation about re-evaluating screening strategies. For instance, broader use of flexible sigmoidoscopy, which examines the lower colon and rectum, could enable earlier detection of rectal cancer.

    This emerging data confirms that rectal cancer in younger adults is no longer rare; it’s now an important public health concern that demands attention. The robustness of the dataset and predictive modeling enhances confidence in the study’s conclusions. Nonetheless, the research relies on existing records and projections, which can’t fully explain the underlying causes—further research into factors like lifestyle, diet, and environmental influences is necessary.

    Ultimately, these findings underscore the importance of not dismissing early symptoms in younger people. Improving awareness, enhancing screening protocols, and implementing early intervention could significantly reduce future death rates from rectal cancer.

    Keep informed on related topics, such as studies indicating that a low-carb diet may increase overall cancer risk, or innovative approaches to extending the survival of cancer patients. Additional research on anti-cancer superfoods and the potential benefits of daily vitamin D3 supplementation for cancer prevention are also worth exploring.

    Source: SUNY Upstate Medical University.

  • Loneliness Might Delay Healing, New Research Suggests

    Loneliness Might Delay Healing, New Research Suggests

    Healing from a wound is generally viewed as a physical process, with doctors concentrating on cleaning the injury, preventing infection, and ensuring the body has enough nutrients to repair tissue. However, recent research indicates that emotional well-being may be equally vital in the healing process.

    A study conducted by researchers at the Medical University of South Carolina and other institutions found that loneliness can impact how effectively wounds heal. Published in the journal Advances in Skin & Wound Care, the research reveals that individuals experiencing loneliness may have delayed healing due to underlying changes within their bodies.

    Chronic wounds are those that fail to heal within four weeks and are common among people with conditions such as diabetes or poor circulation. These wounds can be painful, difficult to treat, and may cause serious complications if not properly managed. The study focused on patients with persistent leg and foot wounds, aiming to understand why some individuals recover more slowly despite receiving appropriate medical treatment.

    Many of these patients seemed to have all the necessary factors for healing—clean wounds, good nutrition, and supportive environments—yet their wounds still didn’t improve as expected. This discrepancy led researchers to consider another factor: loneliness. It’s important to differentiate loneliness from simply being alone; loneliness is the feeling that one’s social relationships lack meaning or support. Someone can be surrounded by many people but still feel lonely.

    To explore this, researchers used the UCLA Loneliness Scale to measure patients’ feelings of social connection. Participants were grouped based on their loneliness levels, and blood samples were analyzed to observe gene activity related to healing. The findings showed notable differences: those with higher loneliness scores exhibited increased activity in genes associated with inflammation. These genes activate the body’s immune response when fighting injury or infection, but they need to turn off after the threat is gone. In lonely individuals, these genes remained active longer than they should, causing prolonged inflammation that hampers healing. A particular group of 18 genes was especially active among those feeling lonely.

    This research aligns with the emerging field of social genomics, which investigates how social experiences influence gene regulation. The evidence from this study underscores that emotional states can directly affect biological functions. It appears that loneliness might induce a persistent stress response in the body, keeping it in a “fight or flight” mode. This chronic stress can weaken immune defenses and slow down wound recovery.

    Fortunately, scientists believe this process can be altered. Future studies are planned to explore whether therapies like cognitive behavioral therapy (CBT) can reduce feelings of loneliness and enhance healing. Early results suggest that changes in gene activity are possible within just a few months of intervention.

    Overall, this research emphasizes the importance of considering patients as complete individuals, not solely their physical ailments. Effective wound care might require addressing emotional health and strengthening social connections alongside medical treatments. However, the study’s small sample size indicates that further research with larger groups is needed to substantiate these findings, as loneliness is a complex issue influenced by multiple factors.

    In summary, the study reveals that emotional health—particularly feelings of loneliness—can profoundly impact physical healing. Recognizing loneliness as a biological factor may lead to new approaches in medical care, especially for those with chronic wounds. Addressing emotional well-being might become a crucial component of recovery strategies in the future.

    If you’re interested in mental health, consider exploring studies about how dairy intake might influence depression risk or how B vitamins could help prevent depression and anxiety. Recent research also suggests that ultra-processed foods may contribute to depression, while extra-virgin olive oil could help reduce symptoms.

    Source: Medical University of South Carolina.

  • Eating sooner may boost heart health, study reveals

    Eating sooner may boost heart health, study reveals

    Many individuals tend to focus primarily on their food choices and portion sizes when aiming to maintain good health. However, emerging research indicates that the timing of meals may be equally important.

    A recent investigation by Northwestern Medicine revealed that syncing eating schedules with the body’s natural sleep cycle can enhance cardiovascular and metabolic health, even if calorie intake remains unchanged.

    Published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology, the study examined a straightforward concept: instead of altering diet or calorie consumption, participants adjusted when they ate. Specifically, they extended their nightly fasting window by about two hours and ensured they stopped eating at least three hours before going to bed.

    Our bodies operate according to an internal clock known as the circadian rhythm, regulating sleep, hormone secretion, metabolism, and other vital functions. When eating habits don’t align with this rhythm, it can interfere with bodily processes, potentially increasing the risk for heart disease, diabetes, and obesity over time.

    The study involved 39 adults aged 36 to 75 who were overweight or obese, placing them at higher risk for metabolic problems. The research spanned roughly seven and a half weeks. Participants were split into two groups: one maintained their usual eating pattern, while the other extended their overnight fasting to between 13 and 16 hours. Additionally, all participants dimmed their lights three hours before bed to support healthier sleep cues and improve circadian alignment.

    Results showed that those who adjusted their mealtime routines experienced positive changes in their cardiovascular health markers. Their blood pressure and heart rate followed healthier patterns overnight—both of which are critical indicators of heart health. Specifically, blood pressure decreased by 3.5%, and heart rate dropped by 5%, indicating better nighttime cardiovascular recovery.

    During daytime hours, these individuals also demonstrated improved blood sugar regulation, suggesting their pancreas was working more effectively to produce insulin. Since poor blood sugar control plays a significant role in the development of type 2 diabetes, this improvement is noteworthy.

    Remarkably, these benefits occurred without any modifications to calorie intake, highlighting that simply shifting meal times can significantly impact health. The researchers believe that eating earlier in the evening allows the body to coordinate metabolism, sleep processes, and heart function more efficiently.

    Participants also found the routine relatively easy to follow, with approximately 90% adhering to the plan. This suggests that such timing adjustments could be a practical approach for many people to incorporate into their lifestyles.

    However, some limitations should be considered. The small sample size and the predominance of female participants mean that further research with larger, more diverse populations is necessary. Additionally, since the study lasted only a few weeks, long-term effects remain unknown.

    Despite these limitations, the findings are promising. They imply that minor lifestyle modifications, like ending meals earlier in the evening, may produce meaningful health benefits. This research underscores the importance of aligning daily habits with our natural biological rhythms—offering a simple, cost-effective strategy to enhance heart and metabolic health, particularly for those at higher risk.

    If you’re interested in heart health, consider reading about how herbal supplements might adversely affect heart rhythms or how consuming eggs can help lower the risk of heart disease.

    For more health insights, explore recent studies suggesting that apple juice could support heart health, and findings indicating that yogurt consumption may reduce mortality risks associated with heart disease.

    Source: Northwestern University.

  • Early 72-Hour Post-Stroke Window Critically Influences Recovery

    Early 72-Hour Post-Stroke Window Critically Influences Recovery

    Credit: Unsplash+

    Many people associate strokes with the moment they occur, but recent research suggests that the hours and days following a stroke are equally critical in determining recovery outcomes.

    A stroke happens when blood flow to the brain is disrupted. This can occur when a blood vessel ruptures, leading to bleeding within the brain, known as a hemorrhagic stroke. Although hemorrhagic strokes are less common than ischemic ones, they tend to result in more severe neurological damage.

    After the bleeding starts, the brain often begins to swell. This swelling results from the injured tissue attracting fluids and triggering inflammation. Since the brain is confined within the skull, there’s limited space to accommodate this expansion. Elevated pressure from swelling can harm surrounding brain tissue.

    A recent study conducted by researchers at the University of Edinburgh and published in Stroke indicates that brain swelling is strongly linked to patient recovery rates.

    The study analyzed data from more than 1,500 stroke patients. Researchers compared brain scans taken at stroke onset, then again at 24 hours and 72 hours later, to observe how swelling evolved.

    Patients were followed up three months after their strokes. It was observed that those with more pronounced increases in swelling were more likely to die or become dependent on others for daily activities.

    The link between swelling and outcomes was gradual but unmistakable. Even small increases in swelling correlated with a higher risk of adverse effects, highlighting how minor brain changes can have serious consequences.

    Among the critical periods was the first day after the stroke, during which swelling appeared to have the strongest connection to poor health outcomes. Changes over the subsequent two days also played a significant role.

    This presents a valuable window for intervention. If medical professionals can intervene within the first three days, it might be possible to limit brain damage.

    Currently, there are no treatments specifically targeting brain swelling post-hemorrhagic stroke. Instead, doctors focus on monitoring patients and managing complications. This study underscores the potential for developing therapies that directly address swelling.

    Researchers are now investigating medications that could reduce brain inflammation, with the goal of controlling swelling and protecting healthy brain cells.

    While these findings are exciting, they should be interpreted carefully. The study demonstrates a strong correlation but does not establish direct causality. Further clinical trials are necessary to determine if reducing swelling genuinely improves recovery outcomes.

    Overall, this research advances our understanding of stroke management, particularly emphasizing the importance of early brain changes and timing in treatment strategies.

    If future studies confirm these results, new therapies might focus on the first few days following a stroke, potentially boosting survival rates and decreasing long-term disabilities.

    If you’re interested in stroke prevention, consider studies suggesting that diets rich in flavonoids could lower stroke risk, and that following the MIND diet may slow cognitive decline after a stroke.

    For additional health insights, examine recent research on antioxidants in reducing dementia risk, and evidence indicating that tea and coffee consumption could help lower the risks of stroke and dementia.

    Source: University of Edinburgh.

  • New Study Reveals Unexpected Gut Bacteria Connection to Parkinson’s

    New Study Reveals Unexpected Gut Bacteria Connection to Parkinson’s

    Credit: Unsplash+

    Parkinson’s disease is a chronic condition that impacts the brain, making it harder for individuals to control their movements. It typically begins subtly, with early signs like tremors, muscle stiffness, or balance issues.

    As the disease advances, everyday tasks become increasingly challenging. For years, researchers have sought to understand what triggers Parkinson’s, but the complete picture has remained elusive.

    Recent studies are shedding new light on how Parkinson’s may start. Instead of focusing solely on the brain, scientists are now exploring the gut—the body system responsible for digestion.

    This region hosts trillions of bacteria, many of which are beneficial and support our health. Yet, some bacteria may have harmful effects, and emerging research suggests they could play a role in Parkinson’s development.

    A team led by Professor Per Saris at the University of Helsinki discovered a strong link between Parkinson’s and a gut bacteria group called Desulfovibrio.

    These bacteria naturally reside in our intestines, with some being harmless. However, certain strains might be damaging and could contribute to the onset of Parkinson’s.

    One hallmark of Parkinson’s is the accumulation of a protein called alpha-synuclein in the brain. This protein can form clumps within neurons, disrupting their function and eventually causing cell damage. These clumps are thought to be key contributors to the disease’s symptoms.

    The study, published in the journal Frontiers in Cellular and Infection Microbiology, found that Desulfovibrio bacteria from Parkinson’s patients significantly increased alpha-synuclein clumping in lab models.

    Conversely, bacteria obtained from healthy individuals didn’t produce the same effect. The harmful strains also generated larger, more toxic protein clumps, indicating they might directly influence disease progression.

    This research supports earlier findings from 2021, which observed that individuals with higher levels of Desulfovibrio bacteria often exhibited more severe Parkinson’s symptoms. Subsequent studies from China reinforced these results, strengthening the case for a connection between this bacteria and the disease.

    Most Parkinson’s cases aren’t inherited but are believed to be triggered by environmental influences. Exposure to specific harmful bacteria could serve as one of the initiating factors. These discoveries offer a fresh perspective on how Parkinson’s might develop.

    Scientists now theorize that harmful Desulfovibrio bacteria could start the disease process in the gut, with protein clumps forming there and then traveling via the vagus nerve to the brain.

    This nerve links the gut and brain, transmitting signals between the two. If protein clumps reach the brain, they may continue to grow and spread, contributing to Parkinson’s symptoms.

    This insight opens exciting possibilities for future treatments. Instead of solely targeting the brain, doctors may develop strategies to eliminate or reduce harmful bacteria in the gut.

    If scientists can identify individuals carrying these detrimental strains, they might be able to intervene early by removing or suppressing them. This could prevent protein clumps from forming, potentially slowing or stopping the disease entirely.

    While there’s no cure yet for Parkinson’s, lifestyle choices can influence risk and health. Regular physical activity—like walking, swimming, or biking—helps maintain strength and may support brain health. A balanced diet rich in fruits, vegetables, whole grains, and lean proteins also promotes overall wellness.

    Protecting your head from injury is vital, as trauma has been linked to an increased risk of Parkinson’s. Reducing exposure to pesticides and other harmful chemicals might also diminish risk, along with avoiding smoking and excessive alcohol use.

    Engaging your mind through mental activities and staying socially connected can benefit brain health. Adequate sleep is essential too, as poor sleep patterns have been associated with a higher likelihood of neurological issues.

    Some research suggests vitamins could offer additional support. For instance, vitamin E might protect brain cells, and vitamin D could be beneficial for those already managing Parkinson’s. Still, more investigation is needed to fully understand these effects.

    This expanding research is reshaping our understanding of Parkinson’s. The link between gut bacteria and the disease provides new hope for early detection and innovative treatment approaches.

    By focusing on both the gut and the brain, scientists may develop future therapies to slow, halt, or even prevent Parkinson’s altogether.

    In the meantime, staying informed on these developments and maintaining a healthy lifestyle remain essential. As ongoing research progresses, these insights could lead to breakthroughs that transform patient care and improve countless lives worldwide.

    If you’re interested in Parkinson’s prevention, consider exploring studies on how vitamin B may slow cognitive decline and how a Mediterranean diet could reduce disease risk.

    Additional information about brain health includes recent findings that blueberry supplements may prevent cognitive decline and that plant-based diets might shield the brain from air pollution effects.

    Copyright © 2026 Knowridge Science Report. All rights reserved.

  • New Non-Addictive Drug Offers Promise for Nerve Pain Relief

    New Non-Addictive Drug Offers Promise for Nerve Pain Relief

    Credit: Unsplash+


    Chronic nerve pain remains one of the toughest health conditions to treat. It impacts millions worldwide and can persist for months or even years.

    This pain, known as neuropathic pain, occurs when nerves outside the brain and spinal cord are damaged. Patients often describe it as burning, stabbing, electric shocks, or tingling sensations. It can significantly disrupt daily activities, sleep quality, mood, and overall health.

    Available treatments for nerve pain are quite limited. Doctors frequently prescribe medications like gabapentin—originally used for seizures—or duloxetine, an antidepressant. While some patients experience relief, these drugs don’t work for everyone and may cause side effects such as dizziness, drowsiness, and nausea.

    In certain cases, opioids are used for pain management. However, these carry serious risks, including addiction, tolerance buildup, and overdose. Over time, patients often need higher doses to achieve pain relief, which increases the danger of adverse effects. Moreover, opioids generally provide limited relief for nerve pain itself.

    Because of these limitations, researchers have been searching for safer, more effective alternatives to manage chronic nerve pain. A recent study from Weill Cornell Medicine and the Burke Neurological Institute offers new hope.

    The research reports a novel drug that successfully reduced nerve pain in initial tests involving rats. Although still in early development stages, the results are promising because the drug alleviated pain without causing typical side effects seen with current therapies.

    This innovative approach hinges on how the drug interacts with nerve cells. In individuals with ongoing nerve pain, certain nerve cells become hyperactive, primarily due to proteins called HCN ion channels. These channels regulate electrical signals within nerves. When they are overly active, they send excessive pain signals to the brain.

    The challenge is that HCN channels aren’t only present in pain nerves—they’re also found in the heart and brain. A drug that blocks these channels systemically could cause serious problems, such as irregular heartbeat or excessive sleepiness.

    To address this, the scientists developed a drug called BP4L-18:1:1. Lead researcher Dr. Gareth Tibbs started with propofol, a medication commonly used to induce anesthesia during surgery. He then modified it by attaching a special “anchor” molecule.

    This anchor keeps the drug localized to nerves outside the brain and spinal cord, preventing it from affecting other parts of the body where it might cause harm. Think of it like tying a boat to a dock—it stays in the right place and doesn’t drift elsewhere. Similarly, the anchor ensures the drug concentrates where it’s needed most.

    Once in position, the drug works by calming down the overactive HCN channels. This reduces the transmission of pain signals to the brain. In animal trials, the drug provided significant pain relief without inducing drowsiness, heart issues, or other major side effects.

    Another key advantage is that the drug can be administered orally, potentially as a simple pill. This would make treatment more accessible and convenient compared to injections or complex therapies.

    The findings are encouraging, suggesting that targeting the root cause of nerve pain might be more effective and safer than broad pain blocking methods. Such an approach could offer new options for those with limited current treatments.

    Dr. Steven Fox, founder of Akelos—a company involved in developing this medication—stated that this method could revolutionize how chronic nerve pain is treated. By focusing on the source rather than just symptoms and minimizing widespread bodily effects, the drug could deliver relief without the risks associated with opioids.

    The research was funded by the Daedalus Fund for Innovation, which aims to translate laboratory discoveries into real-world solutions. The team is hopeful to move into human clinical trials if further testing continues to show positive outcomes.

    It’s important to remember that this work is still in the early stages. Animal studies are a critical step, but more research is needed to confirm safety and effectiveness in humans. Nonetheless, these results offer hope for future treatments that are both safer and more effective.

    For the millions living with chronic nerve pain, this could mark a significant breakthrough. A remedy that alleviates pain without risking addiction or dangerous side effects would be a major advancement in medicine.

    If you’re interested in pain management, consider reading studies on vegetarian women having a higher risk of hip fractures, and how vitamins A, C, and E might help reduce bone fracture risk.

    For additional wellness insights, check out recent research on krill oil’s potential to improve muscle health in older adults, or how eating Jarlsberg cheese daily might help prevent osteoporosis.

    Copyright © 2026 Knowridge Science Report. All rights reserved.

  • Stroke Might Reverse Brain Aging, Study Reveals

    Stroke Might Reverse Brain Aging, Study Reveals

    Credit: Unsplash+

    A stroke is a critical medical event that occurs when blood flow to a part of the brain is blocked or reduced. This interruption can cause damage to brain cells, leading to difficulties with movement, speech, and cognition.

    Many stroke survivors face persistent physical challenges, particularly weakness or paralysis on one side of the body.

    For years, researchers have been exploring how the brain recovers after a stroke. A recent study published in The Lancet Digital Health offers new insights. It suggests that the brain may adapt in ways that scientists hadn’t fully understood before.

    The study was conducted by researchers from the University of Southern California, with collaboration from an international team through the global ENIGMA network. They examined brain scans from more than 500 stroke survivors across 34 research centers in eight different countries.

    The scientists utilized sophisticated artificial intelligence algorithms to analyze MRI scans. They trained models using tens of thousands of brain images to estimate the “age” of different brain regions. It’s important to note that this “brain age” isn’t related to the person’s actual age but reflects how healthy or deteriorated that brain region appears.

    The findings showed that areas of the brain affected by stroke tend to age more rapidly. This isn’t entirely surprising, as injury can weaken brain tissue. What was unexpected, however, was that the healthy side of the brain sometimes appeared biologically younger than expected.

    This “youthful” appearance was most evident in patients with more severe movement impairments. Even months after the stroke, these individuals displayed signs that their undamaged brain regions had undergone changes making them look biologically younger.

    Scientists think this might be a sign that the brain is trying to adapt. When one part of the brain sustains damage, other areas may step in to compensate. This process is called neuroplasticity—the brain’s remarkable ability to rewire itself.

    The study identified the involvement of a particular network called the frontoparietal network, which assists with movement, attention, and coordination. In patients with severe impairments, this network on the healthy side of the brain showed a more “youthful” pattern, indicating adaptive changes.

    It’s important to understand that this doesn’t mean the brain has fully healed. Rather, it indicates that the brain is exerting extra effort to regain function, reorganizing itself to help patients move more effectively and perform daily activities.

    An advantage of this study was its large sample size. By analyzing data from hundreds of participants worldwide, researchers could identify patterns that smaller studies might miss. The use of AI also enabled a deeper understanding of complex brain data in ways that weren’t possible before.

    That said, the research has limitations. It was based on a single snapshot in time and did not follow patients over years. As a result, it can’t fully explain how these brain changes evolve during recovery.

    Ultimately, this research offers fresh perspectives on how the brain reacts to injury. It shows that recovery involves more than just repairing damage; it also includes the brain’s capacity to adapt and reorganize. These insights could lead to more personalized rehab strategies tailored to each individual’s brain changes in the future.

    If you’re interested in stroke-related health tips, check out studies on diets rich in flavonoids that may lower stroke risk and the MIND diet, which might slow cognitive decline post-stroke.

    For additional health insights, explore recent studies on antioxidants that could help prevent dementia, and how drinking tea or coffee may reduce the risk of stroke and cognitive issues in articles like tea and coffee’s potential benefits.

    Source: University of Southern California.

  • AI预测早期肝癌，研究发现

    AI预测早期肝癌，研究发现

    Liver cancer ranks among the most deadly types of cancer worldwide, with hepatocellular carcinoma (HCC) being the most common form. Often developing silently, it’s frequently diagnosed at advanced stages, making treatment more challenging. Early detection is crucial for improving survival rates.

    A recent study published in Cancer Discovery reveals that artificial intelligence could help doctors identify individuals at risk for liver cancer earlier than traditional methods. The research, conducted by scientists from RWTH Aachen University and the Technical University of Dresden, shows promise for transforming screening practices.

    Currently, screening mainly targets those with severe liver conditions like cirrhosis. Yet, many people who develop liver cancer do not have a known history of such diseases, leaving a significant number of at-risk individuals unmonitored. To address this gap, researchers developed a machine learning model that estimates liver cancer risk using straightforward, readily available medical information—such as age, gender, health history from electronic records, and routine blood test results.

    Using data from the UK Biobank, which includes health information from over 500,000 individuals, researchers identified 538 cases of liver cancer. Notably, around 69% of these cases occurred in people without prior diagnosis of major liver diseases. The team trained their model on most of this data and tested it on the remaining samples. They also validated the model using the U.S.-based All of Us registry, which features a more diverse population.

    The model employs a random forest approach, blending multiple decision-making steps to arrive at a final risk assessment. This method enhances accuracy and trustworthiness. Results showed that the model performed exceptionally well, accurately identifying those at risk without relying on complex or expensive genetic tests. In fact, adding sophisticated genetic or genomic data did not significantly improve its performance, suggesting the model’s suitability for broad clinical use, including in resource-limited environments.

    When compared to existing risk assessment tools—such as liver function scores and fibrosis assessments—the new model outperformed them by detecting more true positives while reducing false alarms. Simplifying the model further, using only about 15 common clinical features, still resulted in better performance than traditional methods.

    This research carries several strengths, including the use of large, diverse datasets and validation across different populations, all with a focus on practicality for everyday healthcare. Nonetheless, limitations persist: the model is based on retrospective data and has not yet been tested in prospective clinical trials. Also, key risk groups like those with viral hepatitis were not heavily represented, which may influence overall accuracy.

    Overall, these findings are encouraging. They suggest that simple AI tools could enable earlier identification of patients at risk of liver cancer, potentially guiding timely screening and intervention. This research underscores AI’s potential to revolutionize early cancer detection by leveraging routine health data, ultimately helping more patients receive preventive care.

    For those interested in liver health, exploring simple lifestyle habits that promote liver wellness or investigating common medications like diabetes drugs that may reduce liver inflammation could be worthwhile. Additionally, recent studies highlight the potential for basic blood tests to assess fatty liver disease risk, and evidence indicates that a diet rich in green foods might significantly lower the chances of developing non-alcoholic fatty liver disease.

    Source: RWTH Aachen University.

  • Fruits and Vegetables Linked to Reduced Crohn’s Disease Risk, Study Shows

    Fruits and Vegetables Linked to Reduced Crohn’s Disease Risk, Study Shows

    Credit: Unsplash+

    Crohn’s disease is a chronic condition that impacts the digestive tract. It belongs to the family of illnesses called inflammatory bowel diseases (IBD).

    Individuals with Crohn’s often experience symptoms such as abdominal pain, diarrhea, fatigue, and unintended weight loss. The illness can flare up periodically, and in more severe cases, it may require long-term treatment or surgery.

    The exact cause of Crohn’s remains unclear, but it’s thought to result from a mix of genetic, immune, and environmental factors. Diet is a key environmental element, and many scientists are exploring how the foods we eat daily might influence the risk of developing this disease.

    A recent large-scale study published in the American Journal of Gastroenterology, led by Dr. Antoine Meyer at Université Paris-Saclay in France, shed light on this issue.

    The research examined whether consuming more fruits, vegetables, legumes, and potatoes could influence the likelihood of developing Crohn’s or a related condition called ulcerative colitis.

    The study involved over 341,000 participants who filled out detailed questionnaires about their eating habits. Researchers then tracked these individuals for more than 13 years, on average, to see who developed Crohn’s or ulcerative colitis.

    The results revealed a noteworthy trend: those with higher consumption of fruits, vegetables, legumes, and potatoes had a significantly lower risk of developing Crohn’s disease compared to those with the lowest intake.

    Specifically, individuals with the highest intake were about 56% less likely to develop Crohn’s. This suggests a diet rich in plant foods might help safeguard the digestive system.

    Further analysis identified specific foods that appeared particularly protective. Eating apples, pears, bananas, mushrooms, onions, and garlic was associated with a decreased risk of Crohn’s disease. These foods are packed with fiber, vitamins, and natural compounds that can help promote gut health.

    Fiber, in particular, plays a crucial role in digestion. It helps keep things moving along the gastrointestinal tract and supports the growth of beneficial gut bacteria.

    These beneficial bacteria are vital for immune regulation and inflammation reduction. Since Crohn’s involves inflammation within the digestive system, a fiber-rich diet may provide some degree of protection.

    However, the study did not find a similar link between these foods and ulcerative colitis, another form of IBD. This indicates that Crohn’s and ulcerative colitis might have different triggers and might respond differently to dietary changes.

    Interestingly, the researchers observed that higher potato consumption was linked to an increased risk of ulcerative colitis. While this does not mean potatoes are inherently harmful, it highlights that some foods might affect the two conditions differently. More research is needed to understand these relationships.

    Another key finding was that simply eating a broader variety of fruits, vegetables, legumes, and potatoes did not seem to lower the risk of either disease. It appears that the total quantity of these foods matters more than variety alone.

    While these findings are promising, the authors emphasize the need for further studies to confirm their results. This is especially important for individuals at higher risk, such as those with a family history of IBD.

    It’s also worth noting that some researchers reported ties with the pharmaceutical industry. Although this doesn’t invalidate the findings, it underscores the importance of independent research to verify these results.

    In summary, consuming more fruits, vegetables, and legumes may help reduce the risk of developing Crohn’s disease. Making simple dietary adjustments could promote better gut health, although diet alone isn’t a guarantee against the illness. Continued research will help clarify how food choices can best protect long-term digestive health.

    If you’re interested in gut health, explore studies on how probiotics can safeguard your gut and how mycoprotein might reduce bowel cancer risk and enhance gut health.

    For additional health insights, check recent research on food additives and their impact on gut health and the best foods for supporting gut health.

    © 2026 Knowridge Science Report. All rights reserved.

  • Mosquito-Borne Virus Leads to Years of Joint Pain

    Mosquito-Borne Virus Leads to Years of Joint Pain

    A team of scientists has uncovered a crucial clue explaining why some individuals endure persistent joint pain following infection with the mosquito-borne virus known as chikungunya.

    Chikungunya virus, or CHIKV, is transmitted through mosquito bites and impacts over 110 countries worldwide. The majority of infected individuals experience flu-like symptoms, including fever, fatigue, rash, and joint discomfort, which often resolve within a few weeks.

    However, for certain people, the joint pain persists for months or even years, evolving into a chronic issue that interferes with daily activities. Until now, the reasons behind this prolonged pain remained unclear.

    Researchers at the La Jolla Institute for Immunology in the United States aimed to investigate this phenomenon. Their study, published in the journal Cell Reports Medicine, focused on how the body’s immune system responds after chikungunya infection.

    The immune system functions to defend us from infections by utilizing various cell types to identify and eliminate viruses and bacteria. Among these, T cells are especially important—they help the immune system remember previous infections and respond rapidly if the pathogen reappears.

    There are different T cell subsets, including CD4+ and CD8+ T cells. CD8+ T cells typically target and destroy infected cells directly, while CD4+ T cells support the immune response by guiding other immune cells.

    In this research, scientists analyzed blood samples from individuals in Colombia who had previously fought off chikungunya. They examined how their T cells reacted to small viral fragments.

    What they discovered was unexpected. The CD4+ T cells showed a remarkably strong and enduring response. Even six years after infection, 87% of patients still had these virus-specific CD4+ T cells circulating in their blood. In contrast, only 13% had comparable levels of CD8+ T cells related to the virus.

    This pattern is uncommon for typical viral infections, where CD8+ T cells usually dominate the immune response. Instead, the pattern resembles what is observed in autoimmune diseases, such as rheumatoid arthritis.

    Autoimmune conditions occur when the immune system attacks the body’s own tissues, leading to chronic inflammation and joint deterioration. The scientists suggest a similar process might be occurring in long-term chikungunya cases. The persistent activity of CD4+ T cells could induce ongoing inflammation in the joints, even after the virus has been cleared.

    Additionally, the study noted that these CD4+ T cells often produced a specific inflammatory molecule called TNF-alpha. While normally vital for fighting infections, excessive or prolonged production of TNF-alpha can cause tissue damage.

    In individuals suffering from chronic joint pain, these T cells predominantly produced only TNF-alpha, resulting in a “monofunctional” response—commonly linked to sustained inflammation.

    This insight could explain why pain continues long after the infection has gone. It also hints at potential treatments: medications that block TNF-alpha, already used for autoimmune diseases like rheumatoid arthritis, might be beneficial for those experiencing lengthy joint issues post-chikungunya.

    Researchers are now examining why some groups are more susceptible than others. Preliminary data suggest women in their 40s may be more prone to developing chronic symptoms. Scientists are investigating whether their immune systems are more inclined to mistakenly attack their own tissues.

    This research forms part of broader efforts to understand how viral infections can lead to long-term health problems. Similar patterns have been identified in illnesses linked with other viruses, including dengue and COVID-19.

    Experts increasingly recognize that infections can have lingering effects, with immune responses that persist beyond the initial illness, sometimes causing ongoing health issues.

    While further studies are needed, this research represents a significant advancement in understanding long-term chikungunya symptoms. It offers potential avenues for treatment and improves our grasp of how the immune system may inadvertently contribute to disease.

    Published in Cell Reports Medicine, this work underscores the complex role of the immune system in both fighting infections and sometimes driving chronic disease.

  • Vitamin D2 Supplements Could Reduce Body’s Natural D3, Study Shows

    Vitamin D2 Supplements Could Reduce Body’s Natural D3, Study Shows

    Credit: Unsplash+


    Vitamin D is often called the “sunshine vitamin” because our bodies produce it when skin is exposed to sunlight.

    It plays a vital role in keeping our bones strong and supporting proper immune system function. In many countries, especially those with long winters and limited sunlight, people are encouraged to take vitamin D supplements to keep their levels healthy.

    For instance, in the United Kingdom, the government recommends that individuals consume 10 micrograms of vitamin D daily, particularly from October to March when sunlight is too weak for the body to make enough vitamin D naturally. This advice leads many to rely on supplements to promote their health.

    Recent research indicates that not all vitamin D supplements work equally. Scientists from the University of Surrey, the John Innes Centre, and the Quadram Institute Bioscience have found that one common form of vitamin D supplement could actually lower the levels of the most effective form of vitamin D in the body.

    The study, published in the journal Nutrition Reviews, examined two types of vitamin D supplements: vitamin D2 and vitamin D3. Both are widely available and are used to help maintain adequate vitamin D levels.

    Vitamin D2 typically comes from plant sources and fungi, while vitamin D3 is usually derived from animal products or produced in the skin through sunlight exposure.

    For many years, both forms have been considered acceptable for increasing vitamin D intake. However, the new findings suggest that vitamin D2 might not be as beneficial as once thought.

    The researchers reviewed data from multiple controlled trials where participants received either vitamin D2, D3, or a placebo. These detailed studies help determine true effects by comparing outcomes between groups.

    By analyzing these combined results, the researchers found something surprising: individuals taking vitamin D2 often experienced a decrease in their vitamin D3 levels, which is the form most naturally produced and utilized by the body.

    In some cases, vitamin D3 levels in those taking D2 dropped below levels seen in individuals not taking any supplement at all. This suggests vitamin D2 might interfere with the body’s natural vitamin D3 levels.

    Emily Brown, a PhD researcher and lead author of the study from the University of Surrey’s Nutrition, Exercise, Chronobiology and Sleep research group, emphasized the significance of these findings.

    She explained that vitamin D supplements remain crucial during months when sunlight is insufficient for natural production. Still, this research highlights that vitamin D2 could potentially decrease vitamin D3 levels, a factor not fully appreciated before.

    Given this, many experts recommend vitamin D3 supplements for optimal health, though individual needs should always be taken into account.

    The study also underscores the increasing availability of plant-based vitamin D3 options. Professor Cathie Martin from the John Innes Centre pointed out that improving access to such alternatives could benefit vegetarians and vegans seeking effective supplementation.

    This research supports earlier studies, including one published in Frontiers in Immunology by Professor Colin Smith from the University of Surrey, which indicated that vitamin D3 might influence immune responses differently than vitamin D2.

    Specifically, D3 seems to activate a key component of the immune system called the type I interferon signaling pathway, crucial in defending the body against viruses and bacteria.

    The evidence suggests vitamin D3 may help boost immune defenses, whereas vitamin D2 appears less effective in this regard.

    Since vitamin D is integral to overall health, understanding the differences between its forms is critically important. Deficiency in vitamin D is already a major public health concern, especially in areas with limited sunlight during winter months.

    Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, highlighted that enhancing vitamin D levels across populations is a key health priority.

    He added that many in the UK suffer from low vitamin D, particularly during colder seasons, making it essential to find the most effective ways to supply vitamin D through supplements or fortified foods.

    Overall, the findings suggest that vitamin D3 may be more effective than D2 in improving and maintaining healthy vitamin D levels. The research also raises important questions about how different forms of vitamin D interact within the body and influence health outcomes.

    However, further research is necessary to explore how vitamin D2 might reduce D3 levels long-term and what implications that could have for overall health.

    In conclusion, this study offers valuable insights into vitamin D supplementation, indicating that vitamin D3 might provide greater benefits for most individuals. Better understanding of these differences will help healthcare providers, nutritionists, and policymakers develop more effective recommendations for maintaining optimal vitamin D status.

    If you’re interested in health, explore recent studies on the best times to take vitamins to prevent heart disease or how vitamin D supplements could significantly cut cancer mortality.

    For additional health insights, check out studies on plant nutrients that help lower high blood pressure and antioxidants that may reduce the risk of dementia.

    Copyright © 2026 Knowridge Science Report. All rights reserved.


  • New Study Reveals Statins Are Safer Than Many Believe

    New Study Reveals Statins Are Safer Than Many Believe

    Heart disease continues to be one of the leading health challenges worldwide, claiming approximately 20 million lives each year. In the UK alone, it accounts for about 25% of all fatalities. Conditions like heart attacks and strokes often develop when fatty deposits accumulate inside blood vessels, impeding normal blood flow.

    A widely used strategy to mitigate this risk involves medications known as statins. These drugs primarily focus on lowering LDL cholesterol, often dubbed “bad cholesterol.” When LDL builds up in arteries, it can form plaques that constrict or block blood vessels, eventually leading to severe issues such as heart attacks, strokes, and other cardiovascular problems.

    Because of their effectiveness in reducing cholesterol and safeguarding heart health, statins have become some of the most prescribed medications worldwide, with hundreds of millions of people taking them over the past 30 years. Large-scale clinical studies have demonstrated that statins can notably decrease the chances of having a heart attack or stroke, especially for those already diagnosed with heart disease or at high risk.

    However, despite their proven benefits, some individuals are hesitant to start or continue using statins. Concerns about side effects—such as muscle aches, memory issues, liver complications, or other health concerns—are common barriers. These worries are often fueled by media reports and medication inserts, leading some patients to discontinue treatment or avoid it altogether.

    To assess whether these fears are backed by scientific evidence, researchers analyzed data from extensive clinical trials involving statins. The study was conducted by the Cholesterol Treatment Trialists’ Collaboration, an international group dedicated to studying cholesterol-related treatments.

    They combined data from 23 major randomized controlled trials, involving more than 150,000 participants. Nineteen trials compared individuals taking statins with those receiving a placebo, a harmless, inactive pill, while four trials examined differences between higher- and lower-intensity statin therapies.

    Randomized controlled trials are among the most trusted research methods—they randomly assign participants to different groups, and neither patients nor researchers know who receives the actual medication or the placebo. This approach minimizes bias and helps accurately determine a drug’s true effects.

    Upon reviewing reports of side effects during these trials, the researchers found that most symptoms occurred at similar rates among both statin users and those taking placebos. For instance, reports of memory or cognitive problems were extremely rare—about 0.2% each year—regardless of whether participants took statins or not, suggesting these issues are unlikely caused by the medication.

    The study found no significant increase in risk for most other potential side effects listed on medication labels, including depression, sleep disturbances, erectile dysfunction, headaches, nausea, fatigue, or weight gain. One small difference was noted in liver enzyme levels: about 0.1% more of those on statins showed abnormal liver blood test results. However, these mild abnormalities did not lead to higher rates of serious liver conditions like hepatitis or liver failure and typically did not cause long-term health issues.

    Previous research from the same team examined muscle-related symptoms, a common concern with statins. Those studies concluded that only around 1% of patients experienced muscle problems caused directly by the medication during the first year. After that initial period, there was no increased risk observed.

    Additionally, the researchers confirmed that statins can cause a slight rise in blood sugar levels. For individuals already at risk of diabetes, this could mean developing the disease slightly earlier. Nonetheless, experts agree that the cardiovascular protection offered by statins usually outweighs this minor risk.

    Led by scientists from Oxford Population Health and involving researchers worldwide, the study presents compelling evidence that many widely circulated concerns about statin side effects may not be supported by rigorous scientific data. It also suggests that warnings on medication labels, which are often based on observational studies prone to confounding factors, might need reevaluation.

    By synthesizing evidence from large randomized trials, the researchers have provided a clearer picture of statin safety. While no drug is entirely free of side effects, the data imply that statins are generally much safer than many believe. For most patients at risk of cardiovascular disease, the benefits of these medications considerably outweigh the small chance of adverse effects.

    This study also highlights a crucial issue in modern medicine: misinformation and unfounded fears about medication safety can prevent people from taking treatments that could ultimately save their lives. Stopping statins prematurely, due to unfounded concerns, could increase the risk of heart attacks or strokes.

    Overall, the findings reinforce that statins remain among the most effective tools available for preventing cardiovascular events. Patients who need these medications should feel more confident about continuing their treatment in consultation with their healthcare providers.